Coronavirus: Drugs and Screening

(asked on 20th January 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of (a) levels of access to antiviral and antibody treatment for the clinically vulnerable and clinically extremely vulnerable and (b) provision of priority PCR covid-19 tests for those groups.


Answered by
Maggie Throup Portrait
Maggie Throup
This question was answered on 26th January 2022

From 16 December 2021, up to 1.3 million of the highest risk patients in England have been able to access antiviral or antibody treatments COVID-19 treatments from COVID Medicines Delivery Units.

Deliveries of polymerase chain reaction (PCR) testing kits continue to be made to the highest risk patients in England. Any high risk patients who have not yet received these kits can contact 119 or book an in-person testing appointment. Over 20 million patients in the United Kingdom can access antivirals via the PANORAMIC national study, if they have a positive test result, are aged 50 years old and over or are 18 to 49 years old with an underlying health condition that can increase the risk of developing severe COVID-19.

Reticulating Splines